NAGE · Healthcare · $235M
$2.95+0.34%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기에서 가장 눈에 띄는 건 두 가지 신제품 출시예요.”
In the company's words · 2026 1분기 earnings call